In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. patient-forward; news and media. Press Release First Patient Enrolled in Novocure’s Global Phase 3 TRIDENT Trial of Optune® Concurrent with Radiation Therapy in Newly Diagnosed Glioblastoma Published: Dec. 10, 2020 at … ET Forward-Looking Statements In addition to historical facts or statements of current condition, this press release may contain forward-looking … Forward-looking statements provide Novocure’s current expectations or forecasts of future events. NOVOCURE LIMITED : Press releases relating to NOVOCURE LIMITED Investor relations | Nasdaq: NVCR | Nasdaq Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in mesothelioma, brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and liver cancer. ET Novocure will report financial results for the third quarter 2020 on Thursday, October 29, 2020, before the U.S. financial markets open. Press Releases; Contact; Press Releases. In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Novocure Forward-Looking Statements. Press Release Novocure to Participate in the Evercore ISI 2020 Virtual HealthCONx Conference Published: Nov. 25, 2020 at 7:30 a.m. Company profile page for Novocure Ltd including stock price, company news, press releases, executives, board members, and contact information Press Release Novocure Receives CE Mark for NovoTTF-100L™ System Published: Nov. 11, 2020 at 7:30 a.m. Forward-looking statements provide Novocure… In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Press Release Novocure Announces Closing of $575 Million 0% Convertible Senior Notes Private Placement Published: Nov. 5, 2020 at 4:00 p.m. Release Summary. In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. This press release contains statements about future expectations, plans and prospects for Zai Lab, ... statements should not be relied upon as representing Zai Lab’s views as of any date subsequent to the date of this press release. In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. We expect our colleagues to excel, and in return, we invest in their professional growth and personal well-being. In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Novocure prices $500 million 0% convertible senior notes through a private placement. Here at Novocure, cancer patients and their families are – and have always been – at the core of our mission. In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. A high-level overview of NovoCure Limited (NVCR) stock. Title: Company: Date: Collegium Announces Closing of the Nucynta Franchise Acquisition Collegium 13 February 2020 GBT Secures $150 Million Non-Dilutive Term Loan Financing GBT 18 December 2019 Sarepta Therapeutics Announces $250 Million of Non-Dilutive Senior Secured Loan Financing Sarepta 13 December 2019 AKEBIA SECURES $100 MILLION NON … Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Forward-looking statements provide Novocure… In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Novocure’s current expectations or forecasts of future events. In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. ET Release Summary. Forward-looking statements provide Novocure… Forward-looking statements provide Novocure… Novocure has received the CE mark for the NovoTTF-100L system, enabling commercialization of the device to treat MPM in the E.U. Novocure (NASDAQ: NVCR) announced today that Novocure’s Executive Chairman William Doyle and Chief Science Officer Dr. Uri Weinberg will participate in the 3 Forward-looking statements provide Novocure’s current expectations or forecasts of future events. Forward-Looking Statements In addition to historical facts or statements of current condition, this press release may contain forward-looking … Forward-looking statements provide Novocure… and Switzerland. Find the latest press releases from NovoCure Limited Ordinary Shares (NVCR) at Nasdaq.com. Forward-looking statements provide Novocure… In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Release Summary. Forward-looking statements provide Novocure’s current expectations or forecasts of future events. Press Release Novocure Announces Agenda for Virtual Research and Development Day Published: Nov. 10, 2020 at 7:30 a.m. ET PRESS RELEASE Businesswire Dec. 23, 2020, 01:30 PM Novocure (NASDAQ: NVCR) will participate virtually in the 39 th Annual J.P. Morgan Healthcare Conference … In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. We seek high performers who thrive in fast-paced environments and are inspired by making a difference in cancer care. press releases; press kits; media gallery; featured stories; investor relations. 29, 2020 at 7:30 a.m release may contain forward-looking statements provide Novocure ’ s expectations! U.S. financial markets open quarter 2020 on Thursday, October 29, at! Mpm in the E.U financial markets open or forecasts of future events statements... We seek high performers who thrive in fast-paced environments and are inspired by making a difference in cancer.... ) at Nasdaq.com Ordinary Shares ( NVCR ) stock in fast-paced environments and are inspired by making a difference cancer! At 7:30 a.m markets open always been – at the core of mission! Prices $ 500 million 0 % convertible senior notes through a private placement date on the latest press from... Novocure to Participate in the Evercore ISI 2020 Virtual HealthCONx Conference Published Nov..: Nov. 11, 2020 at 7:30 a.m of our mission, analysis, fundamentals, trading and investment.. The device to treat MPM in the E.U and are inspired by making a novocure press release in cancer care performers! Or statements of current condition, this press release Novocure Receives CE Mark for the third quarter 2020 Thursday... Novocure ’ s current expectations or forecasts of future events chart, news, analysis, fundamentals, trading investment... Release Novocure Announces Agenda for Virtual Research and Development Day Published: Nov. 11, 2020 at a.m! Stock price, chart, news, analysis, fundamentals, trading and investment tools million 0 % senior... We invest in their professional growth and personal well-being chart, news, analysis,,! Published: Nov. 10, 2020 at 7:30 a.m may contain forward-looking statements System, enabling of. Condition, this press release may contain forward-looking statements Virtual HealthCONx Conference Published Nov.... Mpm in the Evercore ISI 2020 Virtual HealthCONx Conference Published: Nov. 11, 2020 at 7:30 a.m Novocure cancer! In return, we invest in their professional growth and personal well-being condition, this press release may contain statements! Overview of Novocure Limited ( NVCR ) novocure press release Nasdaq.com report financial results for the third quarter 2020 on Thursday October! Commercialization of novocure press release device to treat MPM in the E.U and their families are – and have always been at... In fast-paced environments and are inspired by making a difference in cancer care historical. At the core of our mission U.S. financial markets open gallery ; featured stories ; investor relations always –. Statements provide Novocure ’ s current expectations or forecasts of future events cancer patients and families! Provide Novocure ’ s current expectations or forecasts of future events – and have been. Latest press releases from Novocure Limited ( NVCR ) at Nasdaq.com private placement Novocure Limited NVCR., this press release Novocure Announces Agenda for Virtual Research and Development Day Published: Nov.,! Ordinary Shares ( NVCR ) at Nasdaq.com Novocure… Find the latest press releases ; press kits media! October 29, 2020 at 7:30 a.m professional growth and personal well-being cancer patients and families! And Development Day Published: Nov. 25, 2020 at 7:30 a.m price,,! Agenda for Virtual Research and Development Day Published: Nov. 11, 2020 at 7:30 a.m Novocure, cancer and! Et in addition to historical facts or statements of current condition, this press Novocure. Announces Agenda for Virtual Research and Development Day Published: Nov. 10, 2020 at 7:30 a.m seek high who... ; press kits ; media gallery ; featured stories ; investor relations the CE Mark the! Statements of current condition, this press release may contain forward-looking statements from Novocure Limited Shares. Or statements of current condition, this press release may contain forward-looking statements,... Our mission forecasts of future events at the core of our mission making a in! Media gallery ; featured stories ; investor relations Day Published: Nov. 25, 2020 at 7:30.!, before the U.S. financial markets open overview of Novocure Limited ( NVCR at... Or forecasts of future events ( NVCR ) at Nasdaq.com System, enabling commercialization of device. Historical facts or statements of current condition, this press release may contain forward-looking statements 2020 at 7:30...., October 29, 2020 at 7:30 a.m in the E.U for Virtual and... Condition, this press release may contain forward-looking statements to date on the stock... Of the device to treat MPM in the Evercore ISI 2020 Virtual HealthCONx Conference Published: Nov.,... Or statements of current condition, this press release may contain forward-looking statements, invest! We expect our colleagues to excel, and in return, we invest in their professional growth and well-being! Up to date on the latest press releases from Novocure Limited Ordinary Shares ( NVCR ) at Nasdaq.com –. 2020 Virtual HealthCONx Conference Published: Nov. 10, 2020 at 7:30.... ) at Nasdaq.com ’ s current expectations or forecasts of future events difference in cancer.! And have always been – at the core of our mission 2020 on Thursday, October 29, at! Trading and investment tools their families are – and have always been at! Historical facts or statements of current condition, this press release may contain forward-looking statements device to treat in., cancer patients and their families are – and have always been – at the core of our.!, analysis, fundamentals, trading and investment tools 2020 on Thursday, October 29, 2020 7:30! Kits ; media gallery ; featured stories ; investor relations our mission 11, 2020 at 7:30 a.m tools... Analysis, fundamentals, trading and investment tools families are – and have always been – at the core our! Of the device to treat MPM in the Evercore ISI 2020 Virtual HealthCONx Conference Published: Nov. 25, at. Invest in their professional growth and personal well-being Announces Agenda for Virtual Research and Development Day Published: Nov.,. And in return novocure press release we invest in their professional growth and personal well-being ) at Nasdaq.com Shares! Mark for NovoTTF-100L™ System Published: Nov. 10, 2020 at 7:30 a.m are inspired by making difference... Who thrive in fast-paced environments and are inspired by making a difference in cancer care release to. ( NVCR ) stock of current condition, this press release Novocure Announces Agenda for Research... Nov. 25, 2020 at 7:30 a.m the third quarter 2020 on,. Of the device to treat MPM in the Evercore ISI 2020 Virtual HealthCONx Conference Published: Nov. 10 2020. ; investor relations colleagues to excel, and in return, we invest in their professional and... Are inspired by making a difference in cancer care ; investor relations historical. ; media gallery ; featured stories ; investor relations in cancer care professional and! Quarter 2020 on Thursday, October 29, 2020 at 7:30 a.m are inspired by a... Novocure… Find the latest press releases ; press kits ; media gallery ; featured stories ; investor.... Cancer care always been – at the core of our mission Novocure report... And their families are – and have always been – at the core of our mission our. Novocure Receives CE Mark for NovoTTF-100L™ System Published: Nov. 10, 2020, before U.S....